Dr Mevhibe Hocaoglu
Research Assistant, C-CHANGE Study
Phone: 0207 848 5773
Fax: 0207 848 5517
Address: King’s College London
Cicely Saunders Institute
Department of Palliative Care, Policy and Rehabilitation
Denmark Hill, SE5 9PJ
Health services research in vulnerable populations; quality of life; health-related quality of life; patient and validation; qualitative and quantitative research methods
Mev joined the Department of Palliative Care, Policy and Rehabilitation in March 2015 to work on the C-CHANGE project, which aims to develop and validate a patient-centered, nationally applicable casemix classification for adult palliative care provision.
Prior to joining the department, she had been a lecturer in statistics, public health and mental health research and policy. Mev has a PhD degree from the University of Reading where she developed and psychometrically tested the first disease specific health-related quality of life instrument for persons living with Huntington's Disease (HD) with a studentship from the European Huntington's Disease Network. Mevhibe has a BCs (Hons) in Anthropology and Biology from the College of William and Mary (Virginia, USA) and an MSc in Global Health Sciences (University of Oxford).
- Hocaoglu, M. B., Gaffan, E. A. and Ho, A. K. (2012) Health-related quality of life in Huntington’s Disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington’s Disease health-related quality of life questionnaire (HDQoL). Journal of Neurology, 259(9):1793-800. ISSN 1432-1459 doi: 10.1007/s00415-011-6405-2.
- Hocaoglu, M. B., Gaffan, E. A. and Ho, A. K. (2012) The Huntington's Disease health-related Quality of Life questionnaire (HDQoL): a disease-specific measure of health-related quality of life. Clinical Genetics, 81 (2):117-122. ISSN 1399-0004 doi: 10.1111/j.1399-0004.2011.01823.x
- Ho AK, Hocaoglu MB (2011) European Huntington's Disease Network Quality of Life Working Group. Impact of Huntington's across the entire disease spectrum: the phases and stages of disease from the patient perspective. Clinical Genetics, 80(3): pp. 235-9.